Process intensification has become a hot topic in biopharma in recent years, with concepts like continuous manufacturing and “scaling-out” increasingly cited as investment drivers by drug firms and ...

The biopharmaceutical industry’s core mission is the uninterrupted delivery of high-quality, efficacious drugs. At the same time, the industry is under pressure to make production as sustainable as ...